TCEB1

From Wikipedia, the free encyclopedia


Transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)
PDB rendering based on 1lm8.
Available structures: 1lm8, 1lqb, 1vcb, 2c9w, 2fnj, 2izv
Identifiers
Symbol(s) TCEB1; SIII
External IDs OMIM: 600788 HomoloGene38083
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 6921 n/a
Ensembl ENSG00000154582 n/a
Uniprot Q15369 n/a
Refseq NM_005648 (mRNA)
NP_005639 (protein)
n/a (mRNA)
n/a (protein)
Location Chr 8: 75.02 - 75.05 Mb n/a
Pubmed search [1] n/a

Transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C), also known as TCEB1, is a human gene.

This gene encodes the protein elongin C, which is a subunit of the transcription factor B (SIII) complex. The SIII complex is composed of elongins A/A2, B and C. It activates elongation by RNA polymerase II by suppressing transient pausing of the polymerase at many sites within transcription units. Elongin A functions as the transcriptionally active component of the SIII complex, whereas elongins B and C are regulatory subunits. Elongin A2 is specifically expressed in the testis, and capable of forming a stable complex with elongins B and C. The von Hippel-Lindau tumor suppressor protein binds to elongins B and C, and thereby inhibits transcription elongation.[1]

[edit] References

[edit] Further reading

  • Duan DR, Pause A, Burgess WH, et al. (1995). "Inhibition of transcription elongation by the VHL tumor suppressor protein.". Science 269 (5229): 1402–6. PMID 7660122. 
  • Aso T, Lane WS, Conaway JW, Conaway RC (1995). "Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II.". Science 269 (5229): 1439–43. PMID 7660129. 
  • Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG (1995). "Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.". Science 269 (5229): 1444–6. PMID 7660130. 
  • Garrett KP, Haque D, Conaway RC, Conaway JW (1995). "A human cDNA encoding the small subunit of RNA polymerase II transcription factor SIII.". Gene 150 (2): 413–4. PMID 7821821. 
  • Bradsher JN, Jackson KW, Conaway RC, Conaway JW (1994). "RNA polymerase II transcription factor SIII. I. Identification, purification, and properties.". J. Biol. Chem. 268 (34): 25587–93. PMID 8244996. 
  • Pause A, Lee S, Worrell RA, et al. (1997). "The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.". Proc. Natl. Acad. Sci. U.S.A. 94 (6): 2156–61. PMID 9122164. 
  • Lonergan KM, Iliopoulos O, Ohh M, et al. (1998). "Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.". Mol. Cell. Biol. 18 (2): 732–41. PMID 9447969. 
  • Zhang JG, Farley A, Nicholson SE, et al. (1999). "The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation.". Proc. Natl. Acad. Sci. U.S.A. 96 (5): 2071–6. PMID 10051596. 
  • Stebbins CE, Kaelin WG, Pavletich NP (1999). "Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.". Science 284 (5413): 455–61. PMID 10205047. 
  • Pause A, Peterson B, Schaffar G, et al. (1999). "Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein.". Proc. Natl. Acad. Sci. U.S.A. 96 (17): 9533–8. PMID 10449727. 
  • Iwai K, Yamanaka K, Kamura T, et al. (1999). "Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.". Proc. Natl. Acad. Sci. U.S.A. 96 (22): 12436–41. PMID 10535940. 
  • Ohh M, Takagi Y, Aso T, et al. (2000). "Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein.". J. Clin. Invest. 104 (11): 1583–91. PMID 10587522. 
  • Aso T, Yamazaki K, Amimoto K, et al. (2000). "Identification and characterization of Elongin A2, a new member of the Elongin family of transcription elongation factors, specifically expressed in the testis.". J. Biol. Chem. 275 (9): 6546–52. PMID 10692460. 
  • Adryan B, Decker HJ, Papas TS, Hsu T (2000). "Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila.". Oncogene 19 (24): 2803–11. doi:10.1038/sj.onc.1203611. PMID 10851083. 
  • Kamura T, Sato S, Iwai K, et al. (2000). "Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex.". Proc. Natl. Acad. Sci. U.S.A. 97 (19): 10430–5. doi:10.1073/pnas.190332597. PMID 10973499. 
  • Aso T, Yamazaki K, Aigaki T, Kitajima S (2000). "Drosophila von Hippel-Lindau tumor suppressor complex possesses E3 ubiquitin ligase activity.". Biochem. Biophys. Res. Commun. 276 (1): 355–61. doi:10.1006/bbrc.2000.3451. PMID 11006129. 
  • Kamura T, Burian D, Yan Q, et al. (2001). "Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase.". J. Biol. Chem. 276 (32): 29748–53. doi:10.1074/jbc.M103093200. PMID 11384984. 
  • Li Z, Na X, Wang D, et al. (2002). "Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein.". J. Biol. Chem. 277 (7): 4656–62. doi:10.1074/jbc.M108269200. PMID 11739384. 
  • Yamazaki K, Guo L, Sugahara K, et al. (2002). "Identification and biochemical characterization of a novel transcription elongation factor, Elongin A3.". J. Biol. Chem. 277 (29): 26444–51. doi:10.1074/jbc.M202859200. PMID 11994304. 
  • Porkka K, Saramäki O, Tanner M, Visakorpi T (2002). "Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.". Lab. Invest. 82 (5): 629–37. PMID 12004003.